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Abstract
Multicentre randomised trials are complex projects with many operational uncertainties. The embedding of a formal
check upon study progress and viability at a pre-specified time point (sometimes referred to as an ‘internal pilot’) is
becoming increasingly common within multicentre pragmatic randomised trials. However, it is worth considering
this practice. We argue that most, if not all, multicentre trials have reassessment of the recruitment strategy and
study processes whilst the study is running. Additionally, we propose discontinuation of the ‘internal/external pilot
study’ terminology. Instead, we suggest for an alternative taxonomy along with greater recognition of the process
of refinement which routinely occurs in trials and transparent reporting of it.
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Main text
Multicentre randomised trials are complex projects with
many operational uncertainties particularly related to re-
cruitment of participants, set-up of sites, timing and prac-
ticalities of randomisation, and data collection. Whilst,
very valuable, no amount of preliminary (feasibility, pilot-
ing) work can fully remove or anticipate all problems.
Given this, a check upon progress and review of problems
when the study is at an early stage has much to commend
it. The embedding of a formal check upon study viability
at a pre-specified time point (sometimes referred to as an
‘internal pilot study’) is becoming increasingly common
within large multicentre pragmatic randomised trials [1–5].
Based upon a review of the website of one research
programme, around a half of trials funded in 2015 had an
‘internal pilot’ [2]. ‘Internal pilots’ can have a somewhat
ethereal nature to their existence, and they may not be ex-
plicitly reported in published trial report [6]; though with
the publication of trial protocols, they are becoming more
readily identified [7].
Funders naturally want to ensure funds are used effi-
ciently and may request a formalised assessment of
recruitment early in a trial’s lifecycle to identify prob-
lems and potentially curtail trials that are failing [2, 5].
However, it is worth considering this practice. On a
simple level, the increasingly common labelling of this
as an ‘internal pilot study’ is, in our view, unhelpful. A
pilot in the natural sense of the word has to be external
to the thing to which it is a pilot for. In practice, the use
(or not) of the pilot data in the analysis of the trial ap-
pears to be the main dividing line between an ‘internal’
and ‘external’ pilot study [5]. This terminology appears
to have originated from the desire to include a formal
check of key assumptions underlying the sample size
calculation [3, 4, 8]. At the more substantive level, it is
important to recognise that most, if not all, multicentre
trials undergo some modification, and also have regular
reassessment of the recruitment strategy, during their
life course. Typically modifications relate to the recruit-
ment strategy and the data collection process though
other changes, including adjusting the sample size or re-
placing the primary outcome, are not that uncommon
[3–5]. Perhaps some industry-funded drug trials are the
exception where identical study processes can be
adopted from a previous study, and the only distinguish-
ing feature is the active compound. There is though, a
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sense that all trials are unique in the specific combination
of methodology, location, timing and personnel. All trials
have their own ‘story’. This is particularly true of prag-
matic or comparative effectiveness trials, which tend to be
intentional ‘one-offs’. Many, if not all, of the features of an
internal pilot will go on in most (if not all) multicentre tri-
als with only the formal assessment at a specified time the
distinguishing feature. Is there ever a trial conducted with-
out consideration of the recruitment progress against ex-
pectations, or a review of the data collection process?
Indeed, this is one of the responsibilities of trial manage-
ment groups, and similarly, funders may undertake peri-
odic checks on progress. We note that the timing of a
one-off assessment and the specification of stop-go re-
cruitment criteria (typically of the form of X centres hav-
ing recruiting at least one participant and/or a total of Y
participants recruited by month Z) are difficult to get
right. The desire for explicit and applicable criteria needs
to be balanced against the multifaceted nature of the deci-
sion to progress or not. Relevant considerations include
factors external to the trial (e.g. availability of wider re-
sources to support a study with serious recruitment prob-
lems). To recognise this is not to deny the value of a
planned assessment, more the recognition that it is diffi-
cult to anticipate and to formalise all the eventualities and
considerations which go into making decisions relating to
what is a complex, and in some regards, unique project.
Furthermore, regular monitoring of the study process is a
fundamental part of good trial science. It is not without
reason that trial co-ordination and management are in-
creasingly being recognised for its necessity, expertise and
value, and as an emerging area for research [9]. Reports of
trial results however tend to downplay this perhaps due to
fears of how the study might be viewed.
Where can we go from here? First, our proposal is to
stop using the prefixes ‘internal’ and ‘external’; true pilot
studies are always external. A trial which incorporates a
single-planned check of a key aspect of the study (such
as recruitment) could instead refer to a ‘stop-go’ assess-
ment or phase. In Table 1, we suggest an alternative
taxonomy of approaches for developing and modifying
randomised trial design with particular reference to the
recruitment strategy. Clarification of when to use each
approach and what the main output is also given. We
note that the routine monitoring and stop-go assessment
approaches are not mutually exclusive options, and that
the latter is unlikely to be carried out without some
form of the former. Second, trial protocols and reports
should be more transparent about the potential and ac-
tual modification of trial processes and important design
features (e.g. changes to outcomes), and whether it was
a part of a pre-planned refinement process or a response
(very likely a legitimate one) to an unforeseen event.
Due to the difficulties of a one-off assessment, the ‘rou-
tine monitoring’ approach may be the most appropriate
within-trial approach, and in our view better reflects
what often occurs even when a stop-go assessment is
specified. The ACCEPT guidance offers a helpful struc-
ture to think through where uncertainties lie when
deciding upon which approaches to adopt [10]. Third,
there is an underdeveloped area of refinement of meth-
odology and processes during the life course of a trial
which needs exploration and development. BMC Pilot
and feasibility studies is the natural home for publishing
the findings of such work.
Conclusion
Refinement of study processes and reassessment of the
recruitment strategy are key elements of most, if not all,
multicentre randomised trials. There is a sense in which
most have features of an ‘internal pilot study’. We rec-
ommend discontinuation of the terminology of ‘internal’
and ‘external’ pilot studies as it is in our view unhelpful.
There should be greater recognition of the process of
Table 1 Approaches to developing and modifying the trial design with particular reference to the recruitment strategy
Approach Conception When to use Key purpose Main output
Feasibility study Separate study Substantial uncertainty about whether it is
possible or how to implement aspects of
the trial design and conduct (e.g. delivery
of the interventions and recruitment process)
Exploration of the
feasibility of a trial
Assessment of the
feasibility of a trial
Pilot trial Separate study Limited refinement of the trial design,
processes and recruitment strategy
anticipated
Refinement of trial design and
processes prior to commencement
of the main trial
Minor modifications







of the main trial
Substantial adjustment of recruitment
strategy and study processes is
considered likely
One-off within study assessment
of recruitment and study processes
to allow adjustment of the strategy
(including the possibility of





Routine monitoring Throughout the
recruitment period
of the main trial
Minor modifications to study processes
and recruitment strategy anticipated
Regular monitoring to allow
periodic within study modification
Periodic updating of the
recruitment strategy and
study processes
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refinement which occurs routinely in trials, increased
clarity about any planned formal assessment, and more
transparent reporting of this. We have suggested an al-
ternative way to think about this along with a proposed
taxonomy. Further research in this area is needed.
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